Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.
Sanofi - Statistics & Facts
Key insights
- Sanofi revenue in 2023
- 43.1bn EUR
Detailed statistics
Revenue of Sanofi 2006-2023
- Number of Sanofi employees in 2023
- 87,994
Detailed statistics
Sanofi number of employees 2009-2023
- Sanofi expenditure on research and development in 2023
- 6.7bn EUR
Detailed statistics
Sanofi's expenditure on research and development 2008-2023
Editor’s Picks Current statistics on this topic
Current statistics on this topic
Related topics
Recommended statistics
Global positioning
4
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Leading pharmaceutical companies by global vaccine revenue 2021
- Basic Statistic Sales forecast of top pharmaceutical companies worldwide 2028
Global positioning
-
Premium Statistic
Pharmaceutical market: worldwide revenue 2001-2023
Pharmaceutical market: worldwide revenue 2001-2023
Revenue of the worldwide pharmaceutical market from 2001 to 2023 (in billion U.S. dollars)
-
Premium Statistic
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2022 (in billion U.S. dollars)
-
Premium Statistic
Leading pharmaceutical companies by global vaccine revenue 2021
Leading pharmaceutical companies by global vaccine revenue 2021
Leading companies based on global vaccine revenue in 2021 (in billion U.S. dollars)
-
Basic Statistic
Sales forecast of top pharmaceutical companies worldwide 2028
Sales forecast of top pharmaceutical companies worldwide 2028
Sales forecast of leading 10 pharmaceutical companies worldwide in 2028 (in billion U.S. dollars)
Company key figures
-
Basic Statistic
Revenue of Sanofi 2006-2023
Revenue of Sanofi 2006-2023
Revenue of Sanofi from 2006 to 2023 (in million euros)
-
Premium Statistic
Sanofi's net income 2007-2023
Sanofi's net income 2007-2023
Sanofi's net income from 2007 to 2023 (in million euros)
-
Basic Statistic
Sanofi's total assets 2007-2023
Sanofi's total assets 2007-2023
Sanofi's total assets from 2007 to 2023 (in million euros)
-
Premium Statistic
Sanofi number of employees 2009-2023
Sanofi number of employees 2009-2023
Sanofi's number of employees from 2009 to 2023
Business distribution
5
- Premium Statistic Sanofi revenue by region 2023
- Premium Statistic Sanofi - revenue by segment 2014-2023
- Premium Statistic Sanofi pharmaceutical segment revenues by product group 2023
- Premium Statistic Sanofi: human vaccine revenues 2023
- Premium Statistic Sanofi leading pharmaceutical products 2022-2023
Business distribution
-
Premium Statistic
Sanofi revenue by region 2023
Sanofi revenue by region 2023
Revenue of Sanofi by region in 2023 (in million euros)
-
Premium Statistic
Sanofi - revenue by segment 2014-2023
Sanofi - revenue by segment 2014-2023
Revenue of Sanofi by segment from 2014 to 2023 (in million euros)
-
Premium Statistic
Sanofi pharmaceutical segment revenues by product group 2023
Sanofi pharmaceutical segment revenues by product group 2023
Revenue of Sanofi's pharmaceutical segment by product group in 2023 (in million euros)
-
Premium Statistic
Sanofi: human vaccine revenues 2023
Sanofi: human vaccine revenues 2023
Sanofi's human vaccine revenues in 2023, by area of application (in million euros)
-
Premium Statistic
Sanofi leading pharmaceutical products 2022-2023
Sanofi leading pharmaceutical products 2022-2023
Sanofi's selected top pharmaceutical products based on revenue in 2022 and 2023 (in million euros)
Competitors
-
Premium Statistic
GSK's revenue 2006-2023
GSK's revenue 2006-2023
GSK's revenue from 2006 to 2023 (in million British pounds)
-
Premium Statistic
Merck & Co - total revenue 2006-2023
Merck & Co - total revenue 2006-2023
Total revenue of Merck & Co. from 2006 to 2023 (in million U.S. dollars)
-
Premium Statistic
Pfizer's total revenue 2006-2023
Pfizer's total revenue 2006-2023
Pfizer's total revenue from 2006 to 2023 (in million U.S. dollars)
-
Premium Statistic
Eli Lilly's total revenue 2007-2023
Eli Lilly's total revenue 2007-2023
Revenue of Eli Lilly and Company from 2007 to 2023 (in million U.S. dollars)
-
Basic Statistic
Net sales of Novo Nordisk 2009-2023
Net sales of Novo Nordisk 2009-2023
Net sales of Novo Nordisk from 2009 to 2023 (in million DKK)
Research and development
5
- Basic Statistic Sanofi's expenditure on research and development 2008-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Premium Statistic Ongoing R&D projects targeting bacteria as of 2021, by pharmaceutical company
- Basic Statistic Upfront payments by Sanofi in select acquisition and licensing deals 2019-2022
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
Research and development
-
Basic Statistic
Sanofi's expenditure on research and development 2008-2023
Sanofi's expenditure on research and development 2008-2023
Sanofi's expenditure on research and development from 2008 to 2023 (in million euros)
-
Premium Statistic
Top pharma companies worldwide 2024, by size of R&D pipeline
Top pharma companies worldwide 2024, by size of R&D pipeline
Leading 15 pharmaceutical companies worldwide by size of R&D pipeline as of 2024
-
Premium Statistic
Ongoing R&D projects targeting bacteria as of 2021, by pharmaceutical company
Ongoing R&D projects targeting bacteria as of 2021, by pharmaceutical company
Number of ongoing R&D projects targeting bacteria as of 2021, by pharmaceutical company
-
Basic Statistic
Upfront payments by Sanofi in select acquisition and licensing deals 2019-2022
Upfront payments by Sanofi in select acquisition and licensing deals 2019-2022
Upfront payments by Sanofi in select acquisition and licensing deals between December 2019 and March 2022 (in million U.S. dollars)
-
Premium Statistic
BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021 (in million U.S. dollars)
Further reportsGet the best reports to understand your industry
Get the best reports to understand your industry
Contact
Get in touch with us. We are happy to help.
Meredith Alda
Sales Manager– Contact (United States)
Mon - Fri, 9am - 6pm (EST)
Yolanda Mega
Operations Manager– Contact (Asia)
Mon - Fri, 9am - 5pm (SGT)
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)
Lodovica Biagi
Director of Operations– Contact (Europe)
Mon - Fri, 9:30am - 5pm (GMT)
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Mon - Fri, 9am - 6pm (EST)